These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15286008)

  • 1. Is rheumatoid arthritis disappearing?
    Uhlig T; Kvien TK
    Ann Rheum Dis; 2005 Jan; 64(1):7-10. PubMed ID: 15286008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the incidence and severity of rheumatoid arthritis.
    Silman AJ
    J Rheumatol Suppl; 1992 Jan; 32():71-3. PubMed ID: 1535376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of adult rheumatoid arthritis.
    Alamanos Y; Drosos AA
    Autoimmun Rev; 2005 Mar; 4(3):130-6. PubMed ID: 15823498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic studies of rheumatoid arthritis: future directions.
    Heath CW; Fortin PR
    J Rheumatol Suppl; 1992 Jan; 32():74-7; discussion 77-9. PubMed ID: 1613736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of clinically important 10-year health status and disease activity levels in population-based cohorts with rheumatoid arthritis.
    Odegård S; Kvien TK; Uhlig T
    J Rheumatol; 2008 Jan; 35(1):54-60. PubMed ID: 18050381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Declining trend in the incidence of rheumatoid factor-positive rheumatoid arthritis in Finland 1980-2000.
    Kaipiainen-Seppanen O; Kautiainen H
    J Rheumatol; 2006 Nov; 33(11):2132-8. PubMed ID: 17014003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The widening mortality gap between rheumatoid arthritis patients and the general population.
    Gonzalez A; Maradit Kremers H; Crowson CS; Nicola PJ; Davis JM; Therneau TM; Roger VL; Gabriel SE
    Arthritis Rheum; 2007 Nov; 56(11):3583-7. PubMed ID: 17968923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence of rheumatoid arthritis in Spain: results from a nationwide primary care registry.
    Carbonell J; Cobo T; Balsa A; Descalzo MA; Carmona L;
    Rheumatology (Oxford); 2008 Jul; 47(7):1088-92. PubMed ID: 18511475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis.
    Welsing PM; Fransen J; van Riel PL
    Arthritis Rheum; 2005 Sep; 52(9):2616-24. PubMed ID: 16142762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiovascular comorbidity in rheumatic disease. Does sex play a role?].
    Kung M; Störk S; Angermann CE
    Herz; 2005 Sep; 30(6):512-21. PubMed ID: 16170682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors.
    Chakravarty EF; Michaud K; Wolfe F
    J Rheumatol; 2005 Nov; 32(11):2130-5. PubMed ID: 16265690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Absolute risk for fracture and WHO guideline. Epidemiology of rheumatoid arthritis].
    Hakoda M;
    Clin Calcium; 2007 Jul; 17(7):1081-7. PubMed ID: 17607076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers.
    Seong SS; Choi CB; Woo JH; Bae KW; Joung CL; Uhm WS; Kim TH; Jun JB; Yoo DH; Lee JT; Bae SC
    J Rheumatol; 2007 Apr; 34(4):706-11. PubMed ID: 17309133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
    Maradit-Kremers H; Nicola PJ; Crowson CS; O'Fallon WM; Gabriel SE
    J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease?
    Crowson CS; Nicola PJ; Kremers HM; O'Fallon WM; Therneau TM; Jacobsen SJ; Roger VL; Ballman KV; Gabriel SE
    Arthritis Rheum; 2005 Oct; 52(10):3039-44. PubMed ID: 16200583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis.
    Nicola PJ; Crowson CS; Maradit-Kremers H; Ballman KV; Roger VL; Jacobsen SJ; Gabriel SE
    Arthritis Rheum; 2006 Jan; 54(1):60-7. PubMed ID: 16385496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.
    Jacobsson LT; Turesson C; Gülfe A; Kapetanovic MC; Petersson IF; Saxne T; Geborek P
    J Rheumatol; 2005 Jul; 32(7):1213-8. PubMed ID: 15996054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a South European population.
    Abásolo L; Júdez E; Descalzo MA; González-Alvaro I; Jover JA; Carmona L;
    Semin Arthritis Rheum; 2008 Jun; 37(6):388-97. PubMed ID: 17977580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal smoking in pregnancy as a determinant of rheumatoid arthritis and other inflammatory polyarthropathies during the first 7 years of life.
    Jaakkola JJ; Gissler M
    Int J Epidemiol; 2005 Jun; 34(3):664-71. PubMed ID: 15649961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register.
    Askling J; Baecklund E; Granath F; Geborek P; Fored M; Backlin C; Bertilsson L; Cöster L; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; van Vollenhoven R; Klareskog L; Feltelius N
    Ann Rheum Dis; 2009 May; 68(5):648-53. PubMed ID: 18467516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.